Darrell King Lowers stake in Stryker Corporation (SYK)

Stryker Corporation (SYK) : Darrell King reduced its stake in Stryker Corporation by 2.67% during the most recent quarter end. The investment management company now holds a total of 325,110 shares of Stryker Corporation which is valued at $35,440,241 after selling 8,935 shares in Stryker Corporation , the firm said in a disclosure report filed with the SEC on Apr 26, 2016.Stryker Corporation makes up approximately 6.78% of Darrell King’s portfolio.

Stryker Corporation opened for trading at $109.33 and hit $110.22 on the upside on Monday, eventually ending the session at $109.94, with a gain of 0.85% or 0.93 points. The heightened volatility saw the trading volume jump to 9,17,423 shares. Company has a market cap of $41,115 M.

Other Hedge Funds, Including , Wade G W Inc reduced its stake in SYK by selling 79 shares or 3.45% in the most recent quarter. The Hedge Fund company now holds 2,208 shares of SYK which is valued at $240,694. Stryker Corporation makes up approx 0.05% of Wade G W Inc’s portfolio.First Manhattan Co reduced its stake in SYK by selling 6,500 shares or 2.13% in the most recent quarter. The Hedge Fund company now holds 298,595 shares of SYK which is valued at $32,666,293. Stryker Corporation makes up approx 0.20% of First Manhattan Co’s portfolio.Davis R M Inc reduced its stake in SYK by selling 1,430 shares or 0.57% in the most recent quarter. The Hedge Fund company now holds 248,095 shares of SYK which is valued at $27,141,593. Stryker Corporation makes up approx 1.36% of Davis R M Inc’s portfolio.Sigma Planning Corp reduced its stake in SYK by selling 125 shares or 1.37% in the most recent quarter. The Hedge Fund company now holds 9,024 shares of SYK which is valued at $987,226. Stryker Corporation makes up approx 0.13% of Sigma Planning Corp’s portfolio.

On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.

Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Upgraded by Sterne Agee CRT to ” Buy” on Apr 27, 2016. Company shares were Reiterated by RBC Capital Mkts on Apr 26, 2016 to “Outperform”, Firm has raised the Price Target to $ 120 from a previous price target of $108 .Company shares were Downgraded by Robert W. Baird on Apr 13, 2016 to ” Neutral”, Firm has raised the Price Target to $ 116 from a previous price target of $111 .

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Leave a Reply

Stryker Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Stryker Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.